Prochlorperazine dimaleate

Overview

Prochlorperazine dimaleate is an orally active phenothiazine-type dopamine D2 receptor ( D2R ) antagonist. Prochlorperazine exhibits anti-cancer activity in vitro against various cancer cell lines. Prochlorperazine dimaleate exhibits IC 50 values of 6.4 μM, 4.5 μM and 2.3 μM for NOX1 , NOX2 and NOX5 , respectively. Prochlorperazine dimaleate has antedesmosidic activity against dengue virus (DENV). Prochlorperazine dimaleate can be used for research on nausea, vomiting, migraine, and schizophrenia.

Application

Products | Products > Disease Areas > Cancer | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Disease Areas > Inflammation or Immune System Disease | Products > Signaling Pathways > Neuronal Signaling | Products > Signaling Pathways > GPCR/G Protein | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Signaling Pathways > Anti-infection | Products > Research Areas > Neurological Disease | Products > Research Areas > Inflammation/Immunology | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Immunotherapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Dopamine Receptor | Products > Signaling Pathways > NADPH Oxidase | Products > Signaling Pathways > Dengue Virus | Products > Signaling Pathways > Flavivirus

Product Information

• Catalog No.: HY-B0807A
• CAS No.: 84-02-6
• Molecular Formula: C28H32ClN3O8S
• Molecular Weight: 606.09
• Purity: 98.0%
• Storage: 4°C, stored under nitrogen, away from moisture * In solvent : -80°C, 6 months; -20°C, 1 month (stored under nitrogen, away from moisture)
• Solubility: ≥ 2.08 mg/mL (3.43 mM); Clear solution
• Availability: In-stock

Source

Original product source